BYSI

1.70

1.19% 0.02

Handel nachbörslich: 1.70

Beyondspring Inc (BYSI)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose

Schlusskurs vom Vortag:

$1.68

Offen:

$1.66

24-Stunden-Volumen:

7,899

Relative Volume:

0.41

Marktkapitalisierung:

$68.54M

Einnahmen:

$1.88M

Nettoeinkommen (Verlust:

$-15.57M

KGV:

-4.25

EPS:

-0.4

Netto-Cashflow:

$-50.09M

1W Leistung:

+2.41%

1M Leistung:

+13.33%

6M Leistung:

-2.30%

1J Leistung:

-50.44%

1-Tages-Spanne:

$1.64

$1.7544

1-Wochen-Bereich:

$1.62

$1.769

52-Wochen-Spanne:

$0.98

$3.625

Beyondspring Inc Stock (BYSI) Company Profile

Firmenname

Beyondspring Inc

Sektor

Healthcare (1173)

Branche

Biotechnology (666)

Telefon

646-528-4184

Adresse

100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR, FLORHAM PARK, NY

Mitarbeiter

Twitter

@BeyondSpringInc

Nächster Verdiensttermin

2024-08-05

Neueste SEC-Einreichungen

BYSI's Discussions on Twitter

Vergleichen Sie BYSI mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BYSI Beyondspring Inc	1.70	66.93M	1.88M	-15.57M	-50.09M	-0.40
ONC Beigene Ltd Adr	241.43	27.03B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	436.00	112.64B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.335	40.86M	0	0	0	0.00
REGN Regeneron Pharmaceuticals Inc	588.34	64.17B	14.09B	4.50B	2.96B	39.28
VRNA Verona Pharma Plc Adr	75.06	6.07B	0	-153.72M	-103.81M	-2.00

Beyondspring Inc Stock (BYSI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2021-12-02	Herabstufung	BofA Securities	Buy → Underperform
2021-12-02	Herabstufung	Jefferies	Buy → Hold
2021-12-01	Herabstufung	H.C. Wainwright	Buy → Neutral
2021-12-01	Herabstufung	William Blair	Outperform → Mkt Perform
2021-09-09	Eingeleitet	Robert W. Baird	Outperform
2021-08-04	Hochstufung	H.C. Wainwright	Neutral → Buy
2021-04-05	Herabstufung	H.C. Wainwright	Buy → Neutral
2021-01-11	Eingeleitet	BofA Securities	Buy
2020-12-29	Eingeleitet	Evercore ISI	Outperform
2020-02-07	Eingeleitet	Jefferies	Buy
2020-01-10	Eingeleitet	Nomura	Buy
2019-12-03	Eingeleitet	William Blair	Outperform
2019-07-10	Bestätigt	H.C. Wainwright	Buy
2019-04-30	Herabstufung	Maxim Group	Buy → Hold
2018-10-25	Bestätigt	Maxim Group	Buy

Alle ansehen

Beyondspring Inc Aktie (BYSI) Neueste Nachrichten

May 23, 2025

Neutropenia Drugs Market Revenue to Surpass USD 24.2 Billion by 2033 with 4.7% CAGR - openPR.com

May 23, 2025

May 22, 2025

BeyondSpring Reports First?Quarter 2025 Financial Results and Provides Corporate Update | BYSI Stock News - GuruFocus

May 12, 2025

BeyondSpring Inc. Reports Positive Early Results for Plinabulin in Metastatic Cancer and Updates on SEED Therapeutics' Progress - Nasdaq

May 12, 2025

BeyondSpring Reports First‑Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 12, 2025

May 08, 2025

BeyondSpring, Inc. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire

May 08, 2025

May 01, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 01, 2025

Apr 29, 2025

SEED Therapeutics Secures FDA Rare Pediatric and Orphan Drug Designations for ST-01156 - MSN

Apr 29, 2025

Apr 10, 2025

BeyondSpring (NASDAQ:BYSI) Shares Pass Below 50 Day Moving AverageTime to Sell? - MarketBeat

Apr 10, 2025

Apr 04, 2025

BeyondSpring stock hits 52-week low at $1.34 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025

BeyondSpring stock hits 52-week low at $1.34 amid market challenges - Investing.com India

Apr 04, 2025

Mar 30, 2025

BeyondSpring (NASDAQ:BYSI) Trading Down 3.8%Here's Why - MarketBeat

Mar 30, 2025

Mar 29, 2025

BeyondSpring’s 2024 Progress and Strategic Milestones - TipRanks

Mar 29, 2025

Mar 28, 2025

BeyondSpring stock hits 52-week low at $1.4 amid sharp decline By Investing.com - Investing.com South Africa

Mar 28, 2025

BeyondSpring stock hits 52-week low at $1.4 amid sharp decline - Investing.com

Mar 28, 2025

Mar 27, 2025